RSV Vaccine Studies

RSV Vaccines for Seniors

There is no vaccine to prevent RSV infection yet, but researchers are working hard to develop one. RSV infections can be dangerous for certain adults. Each year, it is estimated that more than 177,000 older adults are hospitalized and 14,000 of them die in the United States due to RSV infection. Adults at highest risk for severe RSV infection include older adults, especially those 65 years and older, adults with chronic heart or lung disease, and adults with weakened immune systems.

We are seeking volunteers TODAY for currently enrolling in paid clinical research trials to prevent RSV. Contact us to get information right away on how you can enroll in our ongoing trials to prevent RSV.

RSV Vaccines for Infants & Pregnant Women

RSV is the leading cause of global infant respiratory disease. Infants have much smaller respiratory tracts and airways, so they can have much more severe viral infections. Due to the more severe infection in infants and the impact to their airways, the infection can lead to respiratory distress, hospitalization sometimes requiring intubation, which is a tube placed in your baby’s airway to assist with breathing, or, in some cases, death.

Currently, there is no treatment for RSV, the virus itself. Contact us TODAY to see if you qualify for currently enrolling trials for RSV vaccine clinical trials.

Know someone that’s interested?

Earn $50 for each person you successfully refer to Ventavia Research Group.

Volunteer For A Research Study.

Ventavia Research Group was established with a vision to create a research company that would provide exceptional services to the clinical trial industry and community.